Tuesday, March 12, 2013
Novel Add-on Drug Shows Promise in Alzheimer's Disease
Novel Add-on Drug Shows Promise in Alzheimer's Disease: Adding the selective α-2C adrenoceptor antagonist ORM-12741 to a cholinesterase inhibitor yielded "significant positive" effects on episodic memory in patients with Alzheimer's disease in a phase 2a randomized, double-blind, placebo-controlled study.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment